Purpose Chemoresistance mediated by miRNAs in breast cancer have been already
validated by previous studies in vitro, while little is known concerning the expression of them …

Breast cancer is a complex and heterogeneous disease. Signaling by estrogen receptor
(ER), progesterone receptor (PR), and/or human EGF-like receptor 2 (HER2) is a main driver …

Breast cancer is highest prevailing cancer that incredibly affects women also globally it is the
prominent reason of cancer-related mortality. The untranslated transcripts, called noncoding …

Breast cancer is one of the genetic diseases causing a high mortality among women around
the world. Despite the availability of advanced diagnostic tools and treatment strategies, the …

Breast cancer is a major health problem that affects one in eight women worldwide. As such,
detecting breast cancer at an early stage anticipates better disease outcome and prolonged …

MicroRNAs (miRNAs) are small non-coding RNAs generated by a two-step complex process
and are post transcriptional negative regulators of their target mRNAs. Dysregulation of …

ABSTRACT A large number of etiological factors and the complexity of breast cancers
present challenges for prevention and treatment. Recently, the emergence of microRNAs …

Background Chemotherapy is one of the most common treatment options for breast cancer
(BC) patients. However, about half of the BC patients are chemotherapeutic resistant …

MicroRNAs (miRNAs) are small noncoding RNAs that regulate gene expressions at
posttranscriptional level. Growing evidence points to their significant role in the acquisition of …

Metastatic breast cancer is characterized by aggressive spreading to distant organs. Despite
huge multilevel research, there are still several important challenges that have to be clarified …